Skip to main content.
Debios Diagnostics
Startup
-
Location
Hall 8.0 – 4YFN & Partner District Stand 8.0B10
Information
The company develops FIBROKIT™, the first non-invasive urine test for the detection of renal fibrosis, with clinically validated accuracy comparable to biopsy. It enables earlier diagnosis of chronic kidney disease and improved patient follow-up, supporting more effective and personalised care.
Key Information
-
Pre-Seed
Growth Stage
-
CountrySpain
-
Founding Year2023